Additionally, when mice with STZ-induced diabetes were administered high levels of dietary K+, SGLT2 inhibitors were found to increase urinary K+ excretion while decreasing plasma K+ levels, potentially due to heightened ENaC activity [55]. The gene discussed is SLC5A2; the disease is diabetes mellitus.